PHOENIX -- Selected stroke patients did not benefit clinically from having the window of tenecteplase therapy extended beyond the first few hours of stroke onset, the randomized TIMELESS trial found.

本研究通过分析398例接受机械取栓术（MT）且最终梗死体积（FIV）≤30 ml的前循环大血管闭塞（LVOS）患者数据，首次揭示右侧豆状核（Lentiform Nucleus）受累是90天功能预后不良（mRS>2）的独立预测因子（aOR 3.65，P=0.002），尤其在右半球卒中患者中表现显著。该发现 ...

这篇研究通过回顾性分析两家综合卒中中心352例接受血管内治疗(EVT)的急性大血管闭塞性卒中(LVOS)患者数据，系统探讨了影响院前延迟的关键因素。研究发现：早期呼叫急救服务(OR=0.41)、首诊神经科医生评估(OR=0.35)和卒中识别意识(OR=0.51)是缩短发病至穿刺时间(OTG ...

MENLO PARK, Calif.--(BUSINESS WIRE)--RapidAI, the worldwide leader in advanced imaging for stroke, today announced that Rapid LVO has received Food and Drug Administration (FDA) clearance for ...

Bringing stroke patients straight to the angiography suite of a hospital capable of endovascular therapy reduced hospital delays and improved care for people with suspected large vessel occlusions ...

Please provide your email address to receive an email when new articles are posted on . The RapidAI software successfully processed and identified more eligible large vessel occlusion cases vs. VizAI.

The AI system can identify suspected posterior and anterior large and medium vessel occlusions, aneurysms, and hemorrhages, potentially revolutionizing neurovascular care. Aidoc, a leading Israeli ...

The US Food and Drug Administration (FDA) has granted clearance to the Rapid LVO automated software, which is designed to detect suspected large-vessel occlusions (LVOs). The software may aid the ...

It is the first and only LVO detection software capable of detecting LVOs up to the MCA-M2 level using NCCT Stroke remains a leading cause of disability and death worldwide, and timely treatment ...